Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pommier

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Cancers|December 31, 2020
Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal CancersPaul Giraud, Philippe Giraud, Eliot Nicolas, et al.
Cancer Investigation|March 11, 2014
Intensity modulated arc therapy in bilaterally irradiated head and neck cancer: a comparative and prospective multicenter planning studyStéphanie Servagi Vernat, David Ali, Caroline Messina, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2016
Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck CancerLionel Perrier, Magali Morelle, Pascal Pommier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 11, 2025
Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30)Paul Sargos, Géraldine Pignot, Carine Bellera, et al.
European Urology Oncology|May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical TrialLoic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.
Acta Ophthalmologica|August 16, 2014
Small metastasizing choroidal melanomasAriane Malclès, Tero Kivelä, Zuzana Svetlosakova, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2024
Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASEChloé Buchalet, Claire Lemanski, Pascal Pommier, et al.
Clinical and Translational Radiation Oncology|December 19, 2023
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancerIngrid Masson, Laurène Larriviere, Marc-André Mahé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy groupKanta Ka, Renaud Schiappa, Mario Terlizzi, et al.
JAMA Oncology|June 1, 2023
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical TrialJoël Castelli, Juliette Thariat, Karen Benezery, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Cancers|December 31, 2020
Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal CancersPaul Giraud, Philippe Giraud, Eliot Nicolas, et al.
Cancer Investigation|March 11, 2014
Intensity modulated arc therapy in bilaterally irradiated head and neck cancer: a comparative and prospective multicenter planning studyStéphanie Servagi Vernat, David Ali, Caroline Messina, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2016
Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck CancerLionel Perrier, Magali Morelle, Pascal Pommier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 11, 2025
Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30)Paul Sargos, Géraldine Pignot, Carine Bellera, et al.
European Urology Oncology|May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical TrialLoic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.
Acta Ophthalmologica|August 16, 2014
Small metastasizing choroidal melanomasAriane Malclès, Tero Kivelä, Zuzana Svetlosakova, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2024
Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASEChloé Buchalet, Claire Lemanski, Pascal Pommier, et al.
Clinical and Translational Radiation Oncology|December 19, 2023
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancerIngrid Masson, Laurène Larriviere, Marc-André Mahé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy groupKanta Ka, Renaud Schiappa, Mario Terlizzi, et al.
JAMA Oncology|June 1, 2023
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical TrialJoël Castelli, Juliette Thariat, Karen Benezery, et al.
Pageof 12